Transapical aortic valve and mitral valve in ring prosthesis implantation - a new advance in transcatheter procedures.

Autor: Neves PC; Departments of Cardiothoracic Surgery and Cardiology, Centro Hospitalar de Vila Nova de Gaia/Espinho (CHVNG/E), Vila Nova de Gaia, Portugal pauloacn@gmail.com., Paulo NS; Departments of Cardiothoracic Surgery and Cardiology, Centro Hospitalar de Vila Nova de Gaia/Espinho (CHVNG/E), Vila Nova de Gaia, Portugal., Gama V; Departments of Cardiothoracic Surgery and Cardiology, Centro Hospitalar de Vila Nova de Gaia/Espinho (CHVNG/E), Vila Nova de Gaia, Portugal., Vouga L; Departments of Cardiothoracic Surgery and Cardiology, Centro Hospitalar de Vila Nova de Gaia/Espinho (CHVNG/E), Vila Nova de Gaia, Portugal.
Jazyk: angličtina
Zdroj: Interactive cardiovascular and thoracic surgery [Interact Cardiovasc Thorac Surg] 2014 Aug; Vol. 19 (2), pp. 344-6. Date of Electronic Publication: 2014 Apr 30.
DOI: 10.1093/icvts/ivu137
Abstrakt: Transcatheter valve implantation offers a new treatment modality to those patients whose general condition makes conventional surgery very risky. However, the transcatheter option has only been available for the aortic valve. We describe a case of a successful implantation of two Edwards SAPIEN(®) 26 and 29 mm transapical valves, respectively, in aortic and mitral positions, on a 74-year-old patient with severe aortic and mitral stenosis. The procedure progressed uneventfully. Predischarge echocardiogram showed a peak aortic gradient of 20 mmHg, mild periprosthetic regurgitation, peak and mean mitral gradients of 12 and 4, respectively, and moderate (II/IV) periprosthetic regurgitation. Indications for transapical valve implantation will rapidly increase in the near future. It is essential to individualize the treatment be applied for each patient, in order to optimize the success of the procedure.
(© The Author 2014. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.)
Databáze: MEDLINE